India reviews drug imports: Over 65 patented therapies flagged; agencies seek key cancer, diabetes and cardiac drugs
The government is considering allowing global tenders for essential patented medicines, including treatments for obesity, cancer, and diabetes, to address shortages in India. This move aims to ensure timely access to critical drugs for central healthcare agencies like the armed forces and ESIS, potentially expanding exemptions from domestic sourcing rules.🕒 1 min read
The government is considering allowing global tenders for essential patented medicines, including treatments for obesity, cancer, and diabetes, to address shortages in India. This move aims to ensure timely access to critical drugs for central healthcare agencies like the armed forces and ESIS, potentially expanding exemptions from domestic sourcing rules.
Continue Reading
- Delhi High Court Orders Retrial In 1984 Anti-Sikh Riots Case
- Jharkhand Class 10, 12 Results To Be Declared Soon, Check Details
-
Gautam Gambhir’s Special Ploy For India’s Intra-Squad Match, Copies European Football: Report
-
Dumping allegations: US solar panel manufacturers want tariffs on India, Indonesia & Laos imports; aim to protect billions of dollars of investment
- NASA Astronauts Begin Early Return Flight From ISS With Ailing Crew Member
-
MK Stalin Vows ‘No Entry for BJP’ In Tamil Nadu At DMK’s Mupperum Vizha Celebrations
- Giant 65-Foot Trishul At Kailasagiri Hilltop Lights Up Vizag Skyline
- PSU banks profit may cross Rs 2 lakh crore in FY26; DFS secretary M Nagaraju hints strong credit growth
- Big blow to RCB, Yash Dayal ruled of IPL 2026 due to personal reasons
- India, GCC sign ToR to formally launch FTA talks; pact seen boosting trade, investment flows